ALENDRONIC ACID EFFERVESCENT TABLETS (Binosto®)

Clinical Indication

Osteoporosis

Comments

For patients that cannot swallow tablets.  Not suitable for administration via a feeding tube.

Local guidance

Traffic light changed to green May 2017

Date of classification

August 2016

Green

Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.